Home Emendo Biotherapeutics

Emendo Biotherapeutics

acquired
Series B
Gene Editing Drug Developer

Basic Information

Emendo Biotherapeutics was founded in 2015, with its headquarters located in New York, USA. It is a biotechnology company that utilizes synthetic biology and gene editing technologies to develop drugs for the treatment of currently difficult-to-cure diseases.
Emendo Biotherapeutics Inc
NewYork,NewYork,United States of America
15~50 people
January 01, 2015
info@emendobio.com